Table 2. Factors associated with available PTH levels within 6 months of chronic hypercalcemia (n=7,675).
Covariate | Odds ratio (95% CI) | P value |
---|---|---|
Age | <0.001 | |
<30 years | Reference | |
30–39 years | 2.4 (1.3–4.4) | 0.006 |
40–49 years | 3.2 (1.8–5.6) | <0.001 |
50–59 years | 2.8 (1.6–4.7) | <0.001 |
60–69 years | 2.0 (1.2–3.5) | 0.009 |
70–79 years | 2.0 (1.2–3.5) | 0.01 |
≥80 years | 1.9 (1.1–3.3) | 0.02 |
Sex | <0.001 | |
Male | Reference | |
Female | 1.4 (1.2–1.6) | <0.001 |
Insurance status | 0.02 | |
Commercial | Reference | |
Medicare | 0.86 (0.73–1.0) | 0.09 |
Medicaid | 0.69 (0.55–0.88) | 0.002 |
Other/uninsured/unknown | 0.85 (0.68–1.1) | 0.17 |
Laboratory values | ||
Calcium | <0.001 | |
<11.0 mg/dL | Reference | |
11.1–11.5 mg/dL | 2.8 (2.5–3.3) | <0.001 |
11.6–12.0 mg/dL | 3.9 (3.2–4.7) | <0.001 |
>12.0 mg/dL | 1.7 (1.3–2.1) | <0.001 |
Creatinine | 0.84 (0.71–0.99) | 0.04 |
Indications for surgery | ||
Kidney stones | 1.8 (1.5–2.1) | <0.001 |
Osteoporosis | 3.1 (2.7–3.5) | <0.001 |
Bone fracture | 0.85 (0.66–1.1) | 0.23 |
PTH, parathyroid hormone; CI, confidence interval.